Header Logo

Connection

BENJAMIN LI to Risk Assessment

Back to Details
This is a "connection" page, showing publications BENJAMIN LI has written about Risk Assessment.
BENJAMIN LI
Connection Strength
0.048
Risk Assessment
  1. Neoadjuvant chemotherapy in stage III breast cancer. Am Surg. 2005 Jun; 71(6):487-92.
    View in: PubMed
    Score: 0.031
  2. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome. J Pediatr. 2017 02; 181:102-111.e5.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.